Inovio Pharmaceuticals
INO
#8861
Rank
NZ$0.25 B
Marketcap
NZ$3.71
Share price
-0.46%
Change (1 day)
-46.56%
Change (1 year)

Earnings for Inovio Pharmaceuticals (INO)

Earnings in 2025 (TTM): -NZ$0.19 Billion

According to Inovio Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.18 Million. In 2024 the company made an earning of -NZ$0.19 Billion, an increase over its 2023 earnings that were of -NZ$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Inovio Pharmaceuticals from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.19 Billion1.19%
2024 -NZ$0.19 Billion-20.03%
2023 -NZ$0.24 Billion-51.56%
2022 -NZ$0.48 Billion-8.26%
2021 -NZ$0.52 Billion95.4%
2020 -NZ$0.27 Billion36.62%
2019 -NZ$0.2 Billion20.19%
2018 -NZ$0.17 Billion10.94%
2017 -NZ$0.15 Billion9.59%
2016 -NZ$0.14 Billion118.9%
2015 -NZ$60.64 Million-10.67%
2014 -NZ$67.88 Million83.32%
2013 -NZ$37.03 Million
2011 -NZ$38.2 Million15.64%
2010 -NZ$33.03 Million37.7%
2009 -NZ$23.99 Million2.19%
2008 -NZ$23.48 Million-14.09%
2007 -NZ$27.33 Million19.12%
2006 -NZ$22.94 Million9.62%
2005 -NZ$20.93 Million5.77%
2004 -NZ$19.79 Million73.08%
2003 -NZ$11.43 Million12.75%
2002 -NZ$10.14 Million
2000 -NZ$15.35 Million53.93%
1999 -NZ$9.97 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$20.36 B-11,064.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$55.67 B-30,070.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-NZ$0.13 Billion-30.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$28.21 B-15,289.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
NZ$39.68 B-21,461.43%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$16.02 B-8,724.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
NZ$16.98 B-9,245.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
-NZ$4.74 Million-97.45%๐Ÿ‡บ๐Ÿ‡ธ USA